Sabra Health Care REIT In... (SBRA)
NASDAQ: SBRA
· Real-Time Price · USD
17.43
0.03 (0.17%)
At close: May 29, 2025, 3:59 PM
18.09
3.82%
After-hours: May 29, 2025, 06:40 PM EDT
Sabra Health Care REIT Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Health Care, Resident Service, Ancillary Service Revenue | 3.9M | 2M | 1.5M | 1.3M |
| Health Care, Resident Service, Ancillary Service Revenue Growth | +95.00% | +33.33% | +15.38% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 12.73M | 13.03M | 12.4M | 12.74M | 11.89M | 16.68M | 10.76M | 9.53M | 10.5M | 10.85M | 9.68M | 8.65M | 10.4M | 8.24M | 8.68M | 8.81M | 8.94M | 8.11M | 7.22M | 8.67M | 8.76M | 5.7M | 8.71M | 8.06M | 8.18M | 11.3M | 8.02M | 9.27M | 7.87M | 8.24M | 12.94M | 11.15M | 6.87M | 4.4M | 6.17M | 4.64M | 4.71M | 4.59M | 3.99M | 9.86M | 8M |
| Selling, General, and Administrative Revenue Growth | -2.33% | +5.06% | -2.65% | +7.16% | -28.71% | +55.02% | +12.87% | -9.24% | -3.23% | +12.16% | +11.87% | -16.80% | +26.21% | -5.14% | -1.45% | -1.42% | +10.28% | +12.32% | -16.80% | -1.00% | +53.65% | -34.53% | +8.07% | -1.46% | -27.62% | +40.84% | -13.47% | +17.85% | -4.55% | -36.33% | +16.10% | +62.21% | +56.31% | -28.75% | +33.11% | -1.65% | +2.61% | +15.11% | -59.53% | +23.23% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |